ESCRS - PP24.17 - Capsular Irrigation With Anti-Vegf In Pediatric Cataract Surgery

Capsular Irrigation With Anti-Vegf In Pediatric Cataract Surgery

Published 2022 - 40th Congress of the ESCRS

Reference: PP24.17 | Type: ESCRS 2022 - Posters | DOI: 10.82333/g1y7-bj37

Authors: Alaa Abdalsadek Ahmed Sinjab* 1

1Department of ophthalmology, Sohag University,Sohag Faculty of medicine,Sohag,Egypt

Purpose

To determine the safety and efficacy of irrigation of the capsular bag with anti-VEGF during pediatric cataract surgery

Setting

Department of Ophthalmology, Sohag university Hospital, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.

Methods

15 eyes of 9 children (Age 18-42 months, average 26 months) with isolated congenital cataract underwent irrigation/aspiration with primary PCIOL implantation. Principles included anterior CCC, I/A, irrigation with ranibizumab for two minutes, BSS irrigation, post. CCC, 3-piece IOL inserted in the ciliary sulcus with optic capture.

Control group: 30 eyes of 18 children with isolated congenital cataract underwent the same procedure without use of ranibizumab.

Outcome measures: at 6 months postoperative

Vision, visual axis opacification, postoperative complications.

Results

Vision (preferential looking): Study group ( 12 eyes good vision, 3 eyes fair vision), control group (25 eyes good vision, 5 eyes fair vision), no statistically significant difference.

Postoperative complications: 2ry glaucoma (2 eyes of study group, 3 eyes of control group), early postoperative iritis (1 eye in both groups), no statistically significant difference.

Visual axis opacification and PCO: 4 eyes in study group and 5 eyes in control group, no statistically significant difference.

Conclusions

Irrigation of the capsular bag with ranibizumab during congenital cataract surgery is a safe technique. However, it  showed no additional benefits in preventing PCO. Further studies on large sample are recommended.